Showing results (131-140 of 256) with videos related to
Sort By:
Pageof 26
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 7, 2021
Factors to improve academic publishing success of physicians engaged in scientific researchManuel Neuberger, Christel Weiß, Thomas Stefan Worst, et al.Journal of Endourology|May 25, 2002
Evaluation of superficial papillary ablation by endoscopic lasers in an ex vivo kidney modelThomas Knoll, Maurice Stephan Michel, Armando Cueva-Martínez, et al.Journal of Endourology|March 18, 2003
Objective and subjective changes in patients with Peyronie's disease after management with shockwave therapyMaurice Stephan Michel, Taras Ptaschnyk, Anton Musial, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 5, 2006
Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patientsGunnar Wendt-Nordahl, Harald Rotert, Lutz Trojan, et al.World Journal of Urology|March 29, 2025
Optimizing treatment selection: outcomes of radical cystectomy in patients eligible for trimodal therapyMaurin Helen Mangold, Malin Nientiedt, Frank Waldbillig, et al.Urologic Oncology|December 1, 2007
Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotidesChristian Bolenz, Andreas Becker, Lutz Trojan, et al.Oncology Reports|November 21, 2008
Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinomaUte Gabriel, Christian Bolenz, Andreas Becker, et al.The European Journal of Neuroscience|April 20, 2012
Role of vasoactive intestinal peptide in seasonal encoding by the suprachiasmatic nucleus clockEliane A Lucassen, Hester C van Diepen, Thijs Houben, et al.Urological Research|June 16, 2004
The influence of oxalate on renal epithelial and interstitial cellsThomas Knoll, Annette Steidler, Lutz Trojan, et al.Oncology Reports|July 7, 2009
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancerChristian Bode, Lutz Trojan, Christel Weiss, et al.Pageof 26